Latest Acetylcholinesterase inhibitors Stories
DUBLIN, May 22, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that a panel of the U.S.
- NAMZARIC is now available across the United States - DUBLIN, Ireland, May 18, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that NAMZARIC(TM) (memantine hydrochloride extended-release
DALLAS, February 13, 2015 /PRNewswire/ -- RnRMarketResearch.com adds "Dementia - Pipeline Review, H1 2015" to its store.
- Indicated for Treatment of Moderate to Severe Alzheimer's Disease - DUBLIN and EMERYVILLE, Calif., Dec.
MarketReportsOnline.com adds "Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs Analysis" report to its research store. Dallas,
LONDON, April 1, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
EMERYVILLE, Calif., Jan. 9, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc.
Reportbuyer.com just published a new market research report:
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.